Friday, June 05, 2020 2:36:50 AM
CV Sciences Pipeline
The initial drug candidate (CVSI-007) is a chewing gum containing nicotine and synthetic CBD . . .
CVSI-007 is a Nicotine Replacement Therapy(NRT) drug candidate which has been in the PRECLINICAL Phase since AT LEAST 2015.
That makes CVSI-007 a Candidate For Replacement by already-available "Nicotine Gum + CBD Gummie":
Recent CVSI News
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
